The biggest clinical trial so far to assess a new class of diabetes pills shows that AstraZeneca's Farxiga can prevent heart failure and cut the risk of kidney problems in a broad range of patients.
Original Article: AstraZeneca's diabetes drug curbs heart failure, kidney risks